Regenerative Medical Technology (RMTG) Liabilities and Shareholders Equity (2017 - 2026)
Regenerative Medical Technology (RMTG) reported Liabilities and Shareholders Equity of $5.85 million for Q2 2026, up 30.4% from $4.49 million a year earlier and up 16.8% from the prior quarter.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Regenerative Medical Technology posted Liabilities and Shareholders Equity of $4.49 million, up 17.5% from FY2024.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 82.8% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $3.82 million in FY2024 (+32.7%), $2.88 million in FY2023 (-64.4%), $8.08 million in FY2022 (-13.2%) and $9.31 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since Q2 2023.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last seven quarters, with growth averaging 27.5% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2022 (growth of 828.5%); the low point was Q4 2023 (a decline of 64.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.01 million (Q1 2026), $4.49 million (Q4 2025) and $4.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn | 5.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.85 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 3.82 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 7.54 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 8.08 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.37 Mn |
| Mar 31, 2022 | 8.96 Mn |
| Dec 31, 2021 | 9.31 Mn |
| Sep 30, 2021 | 17.07 Mn |
API Access
Regenerative Medical Technology Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();